Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Patients Receiving Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Large-scale testing (Phase 3)Looking for participantsNCT07669467
What this trial is testing

Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer

Who this might be right for
Fatigue Related to Cancer TreatmentBreast Cancer
Natureceuticals Sdn Bhd 250
Large-scale testing (Phase 3)Study completedNCT02492711
What this trial is testing

Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer

Who this might be right for
HER-2 Positive Breast CancerMetastatic Neoplasm
MacroGenics 624
Testing effectiveness (Phase 2)Looking for participantsNCT04771871
What this trial is testing

MicroRNA Profiles in Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
University College Hospital, Ibadan 42
Not applicableStudy completedNCT02639208
What this trial is testing

Novel Social Media Intervention For Older Br CA Patients

Who this might be right for
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Dana-Farber Cancer Institute 47
Not applicableStudy completedNCT02728596
What this trial is testing

S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)

Who this might be right for
Febrile NeutropeniaStage 0 Breast CancerStage 0 Colorectal Cancer+25 more
SWOG Cancer Research Network 3,665
Testing effectiveness (Phase 2)Active Not RecruitingNCT03386617
What this trial is testing

AKY15-HK-301_NEPA Study

Who this might be right for
Breast Cancer
Chinese University of Hong Kong 55
Early research (Phase 1)WithdrawnNCT03121989
What this trial is testing

Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre
Not applicableStudy completedNCT02485678
What this trial is testing

A Pragmatic Trial of Ambulatory Toxicity Management in Patients Receiving Adjuvant or Neo-adjuvant Chemotherapy for Early Stage Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Ontario Clinical Oncology Group (OCOG) 1,460
Testing effectiveness (Phase 2)UnknownNCT05097248
What this trial is testing

Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Who this might be right for
Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 52
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)UnknownNCT04398446
What this trial is testing

Effect of Hemp-CBD on Patients With CIPN

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyColorectal Cancer Stage IIColorectal Cancer Stage III+4 more
Main Line Health 56
Not applicableNot Yet RecruitingNCT06798506
What this trial is testing

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Triple-negative Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 300
Testing effectiveness (Phase 2)Study completedNCT06538272
What this trial is testing

Study to Investigate the Chemotherapy-Induced Peripheral Neuropathy (CIPN) Onset-Suppressing Effect and Safety of ONO-2910 in Patients With Breast Cancer Receiving Weekly Paclitaxel

Who this might be right for
CIPN - Chemotherapy-Induced Peripheral Neuropathy
Ono Pharmaceutical Co., Ltd. 210
Not applicableUnknownNCT06376357
What this trial is testing

The Effect of Foot Massage With Roles on Cancer Patients

Who this might be right for
Breast NeoplasmsOver CancerFoot Massage
Selcuk University 54
Testing effectiveness (Phase 2)Study completedNCT01594177
What this trial is testing

Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy

Who this might be right for
Unilateral HER2 Positive Breast Cancer
GBG Forschungs GmbH 65
Not applicableStudy completedNCT07015294
What this trial is testing

Effect of a Fruit- and Chaya-Based Diet on Genomic Instability and Biochemical Markers in Women With Breast Cancer Receiving Chemotherapy

Who this might be right for
Breast Cancer
Anahuac Mayab University 13
Testing effectiveness (Phase 2)Study completedNCT01569087
What this trial is testing

Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer

Who this might be right for
Chemotherapy-induced Neutropenia
Biocad 60
Early research (Phase 1)Study completedNCT04187898
What this trial is testing

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Who this might be right for
NeutropeniaBreast Cancer
Spectrum Pharmaceuticals, Inc 59
Testing effectiveness (Phase 2)Study completedNCT03948477
What this trial is testing

Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy

Who this might be right for
OncologyBreast CancerChemotherapy-induced Nausea and Vomiting
University of Auckland, New Zealand 160
Next Page